Aprotinin for coronary artery bypass grafting: Effect on postoperative renal function

The Annals of Thoracic Surgery

Volumn 59, Issue 1, 1995, Pages 132-136

  Lemmer Jr , John H ^a,b,c,d,e,f   Stanford, William ^a,b,c,d,e,f   Bonney, Sharon L ^a,b,c,d,e,f   Chomka, Eva V ^a,b,c,d,e,f   Karp, Robert B ^a,b,c,d,e,f   Laub, Glenn W ^a,b,c,d,e,f   Rumberger, John A ^a,b,c,d,e,f   Schaff, Hartzell V ^a,b,c,d,e,f  

^a UNIVERSITY OF IOWA   (United States)

^b BAYER AG   (Germany)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d DEBORAH HEART AND LUNG CENTER   (United States)

^e UNIVERSITY OF CHICAGO   (United States)

^f MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; CREATININE; PLACEBO;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY BYPASS GRAFT; CORONARY ARTERY DISEASE; CREATININE CLEARANCE; DOUBLE BLIND PROCEDURE; FEMALE; HUMAN; KIDNEY FAILURE; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE HEMORRHAGE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

APROTININ; BLOOD UREA NITROGEN; CORONARY ARTERY BYPASS; CREATININE; DOUBLE-BLIND METHOD; ELECTROLYTES; FEMALE; HUMANS; KIDNEY; KIDNEY FAILURE; MALE; MIDDLE AGED; POSTOPERATIVE COMPLICATIONS; URINE;

EID: 0028891130     PISSN: 00034975     EISSN: None     Source Type: Journal    
DOI: 10.1016/0003-4975(94)00813-M     Document Type: Article

References (21)

1. Reduction in blood loss and blood use after cardiopulmonary bypass with high dose aprotinin (Trasylol)
2. Reduction of homologous blood requirement in cardiac surgery by intraoperative aprotinin application-clinical experience in 152 cardiac surgical patients
3. Influence of high-dose aprotinin treatment on blood loss and coagulation patterns in patients undergoing myocardial revascularization
4. Aprotinin reduces intraoperative and post operative blood loss in membrane oxygenator cardiopulmonary bypass
5. Effects of high-dose aprotinin on blood loss, platelet function, fibrinolysis, complement, and renal function after cardiopulmonary bypass
6. High-dose aprotinin in cardiac surgery: three years' experience in 1784 patients
7. Effect of aprotinin on aorta-coronary bypass graft patency
8. Aprotinin therapy in cardiac operations: a report on use in 41 cardiac centers in the United Kingdom
9. Aprotinin for coronary bypass surgery: efficacy, safety, and influence on early saphenous vein graft patency
10. Aprotinin therapy for reoperative myocardial revascularization: a placebocontrolled study
11. Aprotinin in primary cardiac valve replacement reduces bleeding, increases creatinine
12. Aprotinin in perspective
13. High dose aprotinin therapy: a review of the first five years' experience
14. Pharmacology of aprotinin and efficacy during cardiopulmonary bypass
15. Effects of aprotinin on renal function
16. Segmental nephron function in rats treated with aprotinin, an inhibitor of kallikrein
17. [High-dose aprotinin (Trasylol) therapy-harmless to the kidney?]
18. Safety and risk/benefit ratio of aprotinin in primary CABG
19. Renal dysfunction and intravascular coagulation with aprotinin and hypothermic circulatory arrest
20. Effects of Trasylol on the kidneys-dependence on temperature and dose
21. Aprotinin (Trasylol) protectionunsuitable for hypothermic kidney preservation